Boston Scientific to acquire Pfizer unit
Article Abstract:
Boston Scientific Corp. will purchase Pfizer Inc.'s Schneider Worldwide unit, a maker of medical devices, for $2.1 billion. The purchase will thrust Boston Scientific into the forefront of the expanding market for minimally invasive medicine where Johnson & Johnson is the current leader with about $1.1 billion in sales. Company stock rose while analysts predict that Boston Scientific may become the largest-sales company of medical devices within a year. Boston Scientific acquired a key patent in the deal for Schneider's patented rapid-exchange angioplasty balloon technology.
Comment:
Boston Scientific to buy Pfizer's Scheider Worldwide unit, maker of medical devices, for $2.1 billion
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
J & J agrees to buy DePuy for $3.5 billion
Article Abstract:
DePuy has been acquired by Johnson and Johnson for $3.5 billion in a deal that gives $2.9 billion to Roche Holding AG, which agreed to sell 84% of its interest in DePuy. Johnson and Johnson will become the leading maker of artificial joints and spinal implants in a $9 billion global market for orthopedic devices. Industry analysts said that Johnson and Johnson demonstrated its determination to be a strong presence in the medical-surgical business in a deal that puts it at the top of the profitable joint replacement line, which has about $4 billion in annual global sales.
Comment:
Acquires DePuy Inc. $3.5 billion in a deal that gives $2.9 billion to DePuy stock holder Roche Holding AG
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Conservative Stryker joins the merger game in a big way
Article Abstract:
Stryker Corp.'s announcement that it agreed to acquire Howmedica for $1.9 billion caught investors off guard. Stryker has always been considered to be a conservative operation. The company stated that it would not settle for the status quo. Stryker's proposed deal to buy Howmedica is seen as one of one of the riskiest actions taken by the company in recent years. Howmedica is a division of Pfizer Inc.
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Coming soon (maybe) to a screen near you. Technology as the guiding hand of history
- Abstracts: Hilton Hotels to acquire Grand Casinos and split hotel, gambling operations. Patriot American, unit complete acquisition of interstate hotels
- Abstracts: Phone giant to acquire Bay Networks: Northern Telecom set to pay $9.1 billion. A British phone company looks to America
- Abstracts: British Telecom to acquire MCI's stake in joint venture. MCI reported to be near full Internet sale. In newest deal, Alcatel to buy DSC for stock
- Abstracts: A British phone company looks to America. AT&T chief says he can defend deal